On Wednesday shares of United States Steel Corp. (NYSE:X) closed at $24.81. Company’s sales growth for last 5 years was 9.60% and EPS growth for next 5 years is recorded as -1.31%. United States Steel Corporation (NYSE:X) announced that it will consolidate its North American Flat Rolled operations and temporarily idle its Granite City Works operations in Granite City in Illinois. As part of the consolidation, 2,080 employees at Granite City Works are being issued notices under the Worker Adjustment and Retraining Notification Act.
Groupon, Inc. (NASDAQ:GRPN) in last trading activity increased 2.38% to close at $7.74. Company quarterly performance stands at -2.64%. Groupon, Inc. (NASDAQ:GRPN) is -8.19% away from its 52 week high. Shares of Groupon Inc. (NASDAQ:GRPN) closed up 2.4% on Thursday after an analyst upgraded the stock and said the company is seeing repeat buyers despite concerns that interest in the platform would eventually wane.
On last trading day General Electric Company (NYSE:GE) moved down -1.42% to close at $24.91. Its volatility for the week is 1.19% while volatility for the month is 1.46%. GE’s sales growth for past 5 years was -0.80% and its EPS growth for past 5 years was 8.80%. General Electric Company (NYSE:GE) monthly performance is -1.89%. General Electric Company (NYSE:GE) increased planned job cuts in its Lufkin oilfield equipment unit to 575, as it grapples with pressure on the unit from the drop in oil prices.
On Wednesday shares of SunEdison, Inc. (NYSE:SUNE) closed at $23.82. Company’s sales growth for last 5 years was 16.40% and EPS growth for next 5 years is recorded as 1.58%. SunEdison, Inc. (NYSE: SUNE) announced that it plans to purchase up to 1,000 vanadium flow batteries (over 100 megawatt hours) from Imergy Power Systems, a leader in advanced energy storage solutions.
On last trading day MediciNova Inc. (NASDAQ:MNOV) moved down -5.48% to close at $3.28. Its volatility for the week is 4.02% while volatility for the month is 5.12%. MNOV’s EPS growth for past 5 years was 25.70%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is -7.61%.Biopharmaceutical company MediciNova, Inc. announced that an abstract on the company’s ongoing clinical trial of MN-166 (ibudilast) to address amyotrophic lateral sclerosis (ALS) has been accepted for presentation at the American Academy of Neurology (AAN) 67th Annual Meeting, which will take place on April 18 to 25, 2015 in Washington, DC.